- Investor's Business Daily•10 hours ago
Acorda's inhaled migraine drug could potentially rival a more "novel mechanism" from Eli Lilly.
- Investopedia•14 hours ago
Eli Lilly & Co. reports Q4 results the morning of January 31st. Will its expected strong earnings-per-share results be realized?
- GlobeNewswire•19 hours ago
BOWIE, Md., Jan. 23, 2017-- Inovalon, a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the healthcare ...
LLY : Summary for Eli Lilly and Company Common St - Yahoo Finance
Eli Lilly and Company (LLY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||76.16 - 76.88|
|52 Week Range||64.18 - 83.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||33.20|
|Dividend & Yield||2.08 (2.71%)|
|1y Target Est||N/A|